Nestle Sells Peanut-Allergy Treatment Business to Stallergenes Greer
Published: Sept. 4, 2023 at 1:26 a.m. ET By Adria Calatayud Nestle said it has sold its Palforzia peanut-allergy treatment business to biopharmaceutical company Stallergenes Greer. The Swiss consumer-goods company said Monday that it will receive milestone payments and royalties from Stallergenes Greer. The deal was closed upon signing, Nestle said. The… By Adria Calatayud … Read more